SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-014812
Filing Date
2021-01-22
Accepted
2021-01-22 16:38:51
Documents
1
Effectiveness Date
2021-01-22

Document Format Files

Seq Description Document Type Size
1 S-8 POS d103427ds8pos.htm S-8 POS 16983
  Complete submission text file 0001193125-21-014812.txt   18000
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-237412 | Film No.: 21546325
SIC: 2836 Biological Products, (No Diagnostic Substances)